ARHGEF39 and hepatocellular carcinoma: The overexpression of ARHGEF39 has also been identified in various human malignancies, including non-small cell lung cancer (Zhou et al., 2018), gastric cancer (Wang et al., 2018), and hepatocellular carcinoma (Wang et al., 2012).